Brief: Asit Biotech gets constructive FDA recommendations regarding gp-ASIT+

European Medical Solutions SA

14/11/2016 16:57

Nov 14 (Reuters) - Asit Biotech SA  ASIT.BR : 
    * Constructive recommendations from FDA regarding gp-ASIT+ 
file for preparation of a first clinical trial 
    * Gp-ASIT+ phase III trial results should be available 
during Q1 of 2017 
    * Partnership with SynteractHCR, a north american CRO 
specialized in running clinical trials in field of respiratory 
disorders 
    * Dr. Linda Cox and Dr. Peter Creticos, are joining opinion 
leaders committee for clinical development in United States 
 
Source text for Eikon:  ID:nBw8MQLQPa  
Further company coverage:  ASIT.BR  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))